Rexahn Pharmaceuticals (RNN)
Rexahn Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -2.140M | 0.3892M | -1.469M | -5.829M | -4.436M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | -0.013M | -0.0136M | -0.0136M | -0.0131M | -0.0096M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.36M | -2.653M | -1.718M | -0.4137M | 0.7743M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 0.347M | -2.666M | -1.732M | -0.4268M | 0.7647M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -0.1237M | -2.602M | 0.0399M | 1.191M | 1.246M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -1.916M | -4.879M | -3.161M | -5.065M | -2.426M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.0116M | -0.0022M | -0.0022M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 0.00 | 0.00 | 0.50M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Other Investing Activities | 0.1561M | 1.516M | 0.2304M | 0.1816M | -2.958M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 0.1561M | 1.504M | 0.2282M | 0.6794M | -2.958M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 0.0192M | 0.0221M | 0.00 | 13.56M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.0192M | 0.0221M | 0.00 | 13.56M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -1.760M | -3.356M | -2.911M | -4.385M | 8.173M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 9.862M | 12.34M | 9.862M | 13.22M | 16.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 8.101M | 9.862M | 13.22M | 16.13M | 20.51M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
